摄入量和心力衰竭和高血压的风险:流行病学和门德尔随机化分析
Miao Yuan1, Dingyi Yan2,3, Yu Wang1
1Cardiology Diseases Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Frontiers in nutrition
|February 12, 2024
概括
高摄入量会增加心力衰竭和高血压的风险. 最佳的益处可能发生在每天3000毫克左右,这表明消耗和心血管健康之间存在非线性关系.
科学领域:
- 心血管流行病学心血管流行病学
- 营养科学 营养科学
- 遗传流行病学遗传流行病学
背景情况:
- 摄入量是影响心血管健康的关键饮食因素.
- 以前的研究表明,高摄入量与不良心血管结果之间存在联系.
- 精确的剂量反应关系和最佳摄入水平仍然是研究领域.
研究的目的:
- 研究摄入量与心力衰竭和高血压风险之间的关联.
- 探索摄入量与心血管参数之间的非线性关系.
- 利用流行病学和门德尔随机化方法来评估的影响.
主要方法:
- 来自国家健康和营养检查调查 (NHANES) 数据库的数据分析.
- 流行病学分析以混因素进行调整.
- 孟德尔随机化 (MR) 分析使用尿路作为摄入量的代理.
主要成果:
- 观察到摄入量与心力衰竭风险之间存在非线性关联.
- 增加的尿水平与较高的静缩和静缩血压相关.
- 较高的摄入量与心力衰竭和高血压的风险增加有关.
结论:
- 较高的摄入量与心力衰竭和高血压的风险增加有关.
- 过低的摄入量可能不会带来最大的益处.
- 对心血管健康的最佳益处可以在每天约3000毫克的摄入水平上观察到.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Potassium-Sparing Diuretics
555
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
555
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
640
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
640
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


